ASH 2015 | The azacitidine plus romidepsin clinical trial in lymphoid malignancies

Name: The azacitidine plus romidepsin clinical trial in lymphoid malignancies
Uploaded: 2015-12-04T00:00:00.000Z
Duration: 3 min 39 s
Description: Owen A O'Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about the Phase I trial (NCT01998035) looking into combining oral 5-azacitidine and romidepsin in patients with B-cell and T-cell lymphoma. Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.

Owen O'Connor • 4 Dec 2015

ASH 2015

B-Cell Lymphoma T-Cell Lymphoma Azacitidine Romidepsin

Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about the Phase I trial (NCT01998035) looking into combining oral 5-azacitidine and romidepsin in patients with B-cell and T-cell lymphoma.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.